Delta-Fly Pharma(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4598/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/05/29 | 日証協 | 346,900株 | +5.5% | 58,400株 | -68.12% | 329,716株 | +4.37% | 62,300株 | -30.32% |
2020/05/22 | 日証協 | 328,800株 | +46.79% | 183,200株 | +29.01% | 315,916株 | +28.52% | 89,415株 | -10.94% |
2020/05/15 | 日証協 | 224,000株 | -19.54% | 142,000株 | +53.18% | 245,816株 | -14.12% | 100,400株 | +152.9% |
2020/05/08 | 日証協 | 278,400株 | +36% | 92,700株 | -69.88% | 286,216株 | +19.2% | 39,700株 | -79.83% |
2020/05/01 | 日証協 | 204,700株 | +128.72% | 307,800株 | +391.69% | 240,116株 | +77.53% | 196,800株 | +109.56% |
2020/04/24 | 日証協 | 89,500株 | +40.72% | 62,600株 | +343.97% | 135,252株 | +14.96% | 93,910株 | +396.88% |
2020/04/17 | 日証協 | 63,600株 | +9.09% | 14,100株 | +187.76% | 117,652株 | +4.79% | 18,900株 | +170% |
2020/04/10 | 日証協 | 58,300株 | -0.17% | 4,900株 | -20.97% | 112,275株 | -0.62% | 7,000株 | -43.09% |
2020/04/03 | 日証協 | 58,400株 | +2.1% | 6,200株 | -45.13% | 112,975株 | +8.87% | 12,300株 | -70.8% |
2020/03/27 | 日証協 | 57,200株 | +5.15% | 11,300株 | +264.52% | 103,775株 | +6.49% | 42,123株 | +16.99% |
2020/03/19 | 日証協 | 54,400株 | +6.25% | 3,100株 | -43.64% | 97,447株 | +6.54% | 36,005株 | +81.84% |
2020/03/13 | 日証協 | 51,200株 | -8.08% | 5,500株 | -60.71% | 91,464株 | +11.18% | 19,800株 | +18.55% |
2020/03/06 | 日証協 | 55,700株 | -34.62% | 14,000株 | -19.54% | 82,264株 | -24.71% | 16,702株 | +40.33% |
2020/02/28 | 日証協 | 85,200株 | -32.43% | 17,400株 | -74.3% | 109,260株 | -27.24% | 11,902株 | -81.75% |
2020/02/21 | 日証協 | 126,100株 | -37.82% | 67,700株 | +44.35% | 150,160株 | -36.25% | 65,200株 | +59.4% |
2020/02/14 | 日証協 | 202,800株 | -3.93% | 46,900株 | -44.17% | 235,560株 | +1.21% | 40,903株 | -55.72% |
2020/02/07 | 日証協 | 211,100株 | +66.88% | 84,000株 | +351.61% | 232,740株 | +67.57% | 92,367株 | +155.82% |
2020/01/31 | 日証協 | 126,500株 | -1.4% | 18,600株 | +313.33% | 138,890株 | +5.39% | 36,106株 | +69.51% |
2020/01/24 | 日証協 | 128,300株 | -4.33% | 4,500株 | +1025% | 131,784株 | +0.76% | 21,300株 | +475.68% |
※株式分割は考慮していませんのでご注意ください。
Page Top